$BRKR
BRUKER CORP

2013 Q2 Form 10-Q Financial Statement

#000110465913061802 Filed on August 08, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $454.9M $420.7M
YoY Change 8.13% 4.86%
Cost Of Revenue $253.3M $232.5M
YoY Change 8.95% 6.85%
Gross Profit $201.6M $187.7M
YoY Change 7.41% 2.23%
Gross Profit Margin 44.32% 44.62%
Selling, General & Admin $107.1M $110.6M
YoY Change -3.16% 12.63%
% of Gross Profit 53.13% 58.92%
Research & Development $46.50M $51.90M
YoY Change -10.4% 17.16%
% of Gross Profit 23.07% 27.65%
Depreciation & Amortization $15.00M $15.00M
YoY Change 0.0% 8.7%
% of Gross Profit 7.44% 7.99%
Operating Expenses $158.1M $166.1M
YoY Change -4.82% 14.63%
Operating Profit $43.50M $22.10M
YoY Change 96.83% -42.89%
Interest Expense $3.100M $3.500M
YoY Change -11.43% 118.75%
% of Operating Profit 7.13% 15.84%
Other Income/Expense, Net -$7.800M -$2.800M
YoY Change 178.57% 460.0%
Pretax Income $35.70M $19.30M
YoY Change 84.97% -41.52%
Income Tax $12.40M $9.400M
% Of Pretax Income 34.73% 48.7%
Net Earnings $22.90M $9.900M
YoY Change 131.31% -55.2%
Net Earnings / Revenue 5.03% 2.35%
Basic Earnings Per Share $0.14 $0.06
Diluted Earnings Per Share $0.14 $0.06
COMMON SHARES
Basic Shares Outstanding 166.8M shares 166.0M shares
Diluted Shares Outstanding 168.4M shares 167.1M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $250.9M $240.3M
YoY Change 4.41% 41.52%
Cash & Equivalents $250.9M $240.3M
Short-Term Investments
Other Short-Term Assets $110.6M $102.7M
YoY Change 7.69% -2.1%
Inventory $601.8M $620.3M
Prepaid Expenses
Receivables $300.5M $248.8M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.264B $1.212B
YoY Change 4.27% 3.86%
LONG-TERM ASSETS
Property, Plant & Equipment $287.8M $259.1M
YoY Change 11.08% -2.56%
Goodwill $115.6M $109.8M
YoY Change 5.28%
Intangibles $106.1M $138.5M
YoY Change -23.39%
Long-Term Investments
YoY Change
Other Assets $30.60M
YoY Change 4.79%
Total Long-Term Assets $538.0M $538.0M
YoY Change 0.0% 0.98%
TOTAL ASSETS
Total Short-Term Assets $1.264B $1.212B
Total Long-Term Assets $538.0M $538.0M
Total Assets $1.802B $1.750B
YoY Change 2.95% 2.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $69.50M $77.40M
YoY Change -10.21% -5.61%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $1.100M $77.60M
YoY Change -98.58% 84.32%
Total Short-Term Liabilities $602.8M $751.9M
YoY Change -19.83% -16.61%
LONG-TERM LIABILITIES
Long-Term Debt $335.4M $243.3M
YoY Change 37.85% 304.15%
Other Long-Term Liabilities $140.9M $113.3M
YoY Change 24.36% 5.69%
Total Long-Term Liabilities $476.3M $356.6M
YoY Change 33.57% 113.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $602.8M $751.9M
Total Long-Term Liabilities $476.3M $356.6M
Total Liabilities $1.083B $1.111B
YoY Change -2.56% 3.63%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 32.65K shares 20.83K shares
Shareholders Equity $718.9M $638.7M
YoY Change
Total Liabilities & Shareholders Equity $1.802B $1.750B
YoY Change 2.95% 2.95%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $22.90M $9.900M
YoY Change 131.31% -55.2%
Depreciation, Depletion And Amortization $15.00M $15.00M
YoY Change 0.0% 8.7%
Cash From Operating Activities -$6.700M $37.10M
YoY Change -118.06% 876.32%
INVESTING ACTIVITIES
Capital Expenditures -$16.50M -$18.80M
YoY Change -12.23% -11.74%
Acquisitions
YoY Change
Other Investing Activities -$1.300M $900.0K
YoY Change -244.44% -181.82%
Cash From Investing Activities -$17.80M -$17.90M
YoY Change -0.56% -20.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.400M 2.700M
YoY Change -11.11% -127.27%
NET CHANGE
Cash From Operating Activities -6.700M 37.10M
Cash From Investing Activities -17.80M -17.90M
Cash From Financing Activities 2.400M 2.700M
Net Change In Cash -22.10M 21.90M
YoY Change -200.91% -176.84%
FREE CASH FLOW
Cash From Operating Activities -$6.700M $37.10M
Capital Expenditures -$16.50M -$18.80M
Free Cash Flow $9.800M $55.90M
YoY Change -82.47% 122.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1400000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3200000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3800000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1900000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
22900000 USD
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166800000 shares
CY2013Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1600000 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.14
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.06
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.17
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.15
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
28300000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1600000 shares
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
9900000 USD
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166000000 shares
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
25000000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165900000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168400000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
166600000 shares
CY2012Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1100000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
168200000 shares
CY2012Q2 brkr Demonstration Inventory Write Down
DemonstrationInventoryWriteDown
7300000 USD
brkr Demonstration Inventory Write Down
DemonstrationInventoryWriteDown
16000000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
100400000 USD
CY2013Q2 brkr Demonstration Inventory Write Down
DemonstrationInventoryWriteDown
8200000 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
106100000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
199000000 USD
CY2013Q2 us-gaap Other Inventory In Transit
OtherInventoryInTransit
64100000 USD
brkr Demonstration Inventory Write Down
DemonstrationInventoryWriteDown
14100000 USD
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1100000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
167000000 shares
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
197000000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
160500000 USD
CY2012Q4 us-gaap Other Inventory Demo
OtherInventoryDemo
55000000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
611500000 USD
CY2012Q4 us-gaap Other Inventory In Transit
OtherInventoryInTransit
93900000 USD
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
197300000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
204100000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
148000000 USD
CY2013Q2 us-gaap Other Inventory Demo
OtherInventoryDemo
52400000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
601800000 USD
CY2012Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1400000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
115900000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
115600000 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
-300000 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-600000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
167000000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
55700000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
111300000 USD
CY2012Q4 brkr Intangible Assets Excluding Goodwill Gross
IntangibleAssetsExcludingGoodwillGross
172700000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
117000000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
167400000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
67000000 USD
CY2013Q2 brkr Intangible Assets Excluding Goodwill Gross
IntangibleAssetsExcludingGoodwillGross
173100000 USD
CY2013Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5100000 USD
CY2012Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5600000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10200000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10700000 USD
CY2012Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
16400000 USD
CY2012Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.487 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.341 pure
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
42100000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
23600000 USD
CY2012Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
100000 USD
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
-400000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25300000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3700000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000000 USD
CY2013Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.347 pure
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
337200000 USD
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
336500000 USD
CY2013Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
335400000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1300000 USD
CY2012Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
335900000 USD
brkr Foreign Currency Contract Typical Maturity Period Maximum
ForeignCurrencyContractTypicalMaturityPeriodMaximum
P12M
us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
900000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
5400000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12400000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21200000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.459 pure
CY2013Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
36100000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
17500000 USD
CY2013Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
3300000 USD
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
200000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
23300000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
9900000 USD
us-gaap Profit Loss
ProfitLoss
29000000 USD
us-gaap Profit Loss
ProfitLoss
25000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-15900000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-34700000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4300000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-200000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
400000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-700000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-900000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-1700000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
9900000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-300000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
10100000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-23500000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
28300000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
400000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
700000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
100000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27900000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23500000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4700000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
10000000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
170300000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
145000000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-25300000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
32500000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
30800000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-1000000 USD
us-gaap Other Comprehensive Income Reclassification Of Defined Benefit Plans Net Gain Loss Recognized In Net Periodic Benefit Cost Net Of Tax
OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCostNetOfTax
700000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
137800000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
114200000 USD
brkr Other Comprehensive Income Arising During Period Net Of Tax
OtherComprehensiveIncomeArisingDuringPeriodNetOfTax
-24300000 USD
brkr Other Comprehensive Income Reclassification Adjustment Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentIncludedInNetIncomeNetOfTax
-700000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23600000 USD
brkr Other Comprehensive Income Reclassification Adjustment Included In Net Income Tax
OtherComprehensiveIncomeReclassificationAdjustmentIncludedInNetIncomeTax
100000 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
3100000 USD
CY2011Q4 us-gaap Minority Interest
MinorityInterest
3400000 USD
CY2013Q2 us-gaap Minority Interest
MinorityInterest
3800000 USD
CY2012Q2 us-gaap Minority Interest
MinorityInterest
2900000 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
400000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
700000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
100000 USD
CY2013Q2 us-gaap Legal Fees
LegalFees
2400000 USD
CY2013Q2 brkr Factory Relocation Charges
FactoryRelocationCharges
200000 USD
CY2013Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
100000 USD
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
1800000 USD
CY2013Q2 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
4500000 USD
us-gaap Legal Fees
LegalFees
4600000 USD
brkr Factory Relocation Charges
FactoryRelocationCharges
500000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
500000 USD
us-gaap Restructuring Charges
RestructuringCharges
5000000 USD
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
10600000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
709700000 USD
CY2012Q2 us-gaap Legal Fees
LegalFees
2200000 USD
CY2012Q2 brkr Factory Relocation Charges
FactoryRelocationCharges
600000 USD
CY2012Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
800000 USD
CY2012Q2 us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
3600000 USD
us-gaap Other Nonrecurring Expense
OtherNonrecurringExpense
7000000 USD
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1200000 USD
brkr Factory Relocation Charges
FactoryRelocationCharges
1100000 USD
us-gaap Legal Fees
LegalFees
4700000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
3100000 USD
CY2013Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-4700000 USD
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7800000 USD
us-gaap Interest Expense
InterestExpense
6800000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2300000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10300000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1300000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11700000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
3500000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1200000 USD
us-gaap Interest Expense
InterestExpense
6200000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5100000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
900000 USD
CY2012Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
700000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2800000 USD
us-gaap Revenues
Revenues
848300000 USD
CY2013Q2 us-gaap Assets
Assets
1801800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
55700000 USD
CY2013Q2 us-gaap Revenues
Revenues
454900000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
43500000 USD
CY2012Q2 us-gaap Revenues
Revenues
420700000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
22100000 USD
us-gaap Revenues
Revenues
826300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
56500000 USD
CY2012Q4 us-gaap Assets
Assets
1856400000 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">1.</font></b><b><font style="FONT-SIZE: 3pt; FONT-WEIGHT: bold;" size="1">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></b> <b><font style="FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Description of Business</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker Corporation, together with its consolidated subsidiaries (&#8216;&#8216;Bruker&#8217;&#8217; or the &#8216;&#8216;Company&#8217;&#8217;), is a designer and manufacturer of proprietary life science and materials research systems and associated products that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company has two reporting segments, <i>Bruker Scientific Instruments (BSI)</i>, which represents approximately 93% of the Company&#8217;s revenues during the six months ended June&#160;30, 2013, and <i>Bruker Energy&#160;&amp; Supercon Technologies (BEST)</i>, which represents the remainder of the business.&#160; Within BSI, the Company is organized into three operating segments: the Bruker BioSpin group, the Bruker CALID group, and the Bruker MAT group. For financial reporting purposes, the Bruker BioSpin, Bruker CALID and Bruker MAT operating segments are aggregated into the BSI reporting segment because each has similar economic characteristics, production processes and services, types and classes of customers, methods of distribution and regulatory environments.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="MARGIN: 0in 0in 0pt 0.25in;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker BioSpin</font></i><font style="FONT-SIZE: 10pt;" size="2">- Bruker BioSpin focuses on designing, manufacturing and distributing enabling life science tools based on magnetic resonance technology.&#160; Bruker BioSpin sells various systems utilizing magnetic resonance technology, including magnetic resonance imaging systems (pre-clinical MRI), nuclear magnetic resonance systems (NMR), and electron paramagnetic resonance systems (EPR). Additionally, Bruker BioSpin supplies OEM MRI magnets to medical device manufacturers.</font></p> <p style="MARGIN: 0in 0in 0pt 0.25in;">&#160;</p> <p style="MARGIN: 0in 0in 0pt 0.25in;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker CALID</font></i> <font style="FONT-SIZE: 10pt;" size="2">(<u>C</u>hemicals, <u>A</u>pplied Markets, <u>L</u>ife Science,&#160;<u>I</u>n-Vitro Diagnostics, <u>D</u>etection)- Bruker CALID manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as Chemical, Biological, Radiological, Nuclear, Explosives (CBRNE) detection products and instruments based on infrared and Raman molecular spectroscopy technologies.&#160; Bruker CALID&#8217;s mass spectrometry units are typically used in applications of expression proteomics, clinical proteomics, metabolic and peptide biomarker profiling, drug discovery and development, molecular diagnostics research, molecular and systems biology, and basic molecular medicine research and clinical microbiology (for research use only outside the European Union).</font></p> <p style="MARGIN: 0in 0in 0pt 0.25in;">&#160;</p> <p style="MARGIN: 0in 0in 0pt 0.25in;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker MAT (Materials)</font></i><font style="FONT-SIZE: 10pt;" size="2">- Bruker MAT manufactures and distributes advanced X-ray instruments that use electromagnetic radiation with extremely short wavelengths to determine the characteristics of matter and the three-dimensional structure of molecules. Instruments offered in this segment are based on X-ray fluorescence spectroscopy (XRF), X-ray diffraction (XRD), X-ray micro computed tomography (&#181;CT) technologies. Other instruments include atomic force microscopy (AFM), stylus and optical metrology (SOM), analytical tools for electron microscopes, handheld, portable, and mobile X-ray fluorescence, spectrometry instruments, and spark optical emission spectroscopy systems.</font></p> <p style="MARGIN: 0in 0in 0pt 0.25in;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company&#8217;s <i>BEST</i> reporting segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and &#8216;&#8216;big science&#8217;&#8217; research. The segment focuses on metallic low temperature superconductors for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications, and ceramic high temperature superconductors primarily for energy grid and magnet applications.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The unaudited condensed consolidated financial statements represent the consolidated accounts of the Company. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements as of June&#160;30, 2013 and December&#160;31, 2012 and for the three and six months ended June&#160;30, 2013 and 2012, have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) for interim financial information and pursuant to the rules&#160;and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;) for Quarterly Reports on Form&#160;10-Q and Article&#160;10 of Regulation S-X. Accordingly, the financial information presented herein does not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation have been included. The results for interim periods are not necessarily indicative of the results expected for any other interim period or the full year. Certain prior year amounts have been reclassified to conform to the current year presentation and had no effect on previously reported net income or cash flows.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company has evaluated all subsequent events and determined that there are no material recognized or unrecognized subsequent events requiring disclosure.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">At June&#160;30, 2013, the Company&#8217;s significant accounting policies and estimates, which are detailed in the Company&#8217;s Annual Report on Form&#160;10-K for the year ended December&#160;31, 2012, have not changed.</font></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> </div>
dei Entity Registrant Name
EntityRegistrantName
BRUKER CORP
dei Entity Central Index Key
EntityCentralIndexKey
0001109354
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
167149191 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
310600000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
289300000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
98300000 USD
us-gaap Net Income Loss
NetIncomeLoss
25000000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1309700000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
283600000 USD
CY2012Q4 brkr Intangibles And Other Long Term Assets Noncurrent
IntangiblesAndOtherLongTermAssetsNoncurrent
263100000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
69600000 USD
CY2012Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
267300000 USD
CY2012Q4 brkr Others Shareholders Equity
OthersShareholdersEquity
567300000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
706600000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
343600000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
681800000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
129000000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
1700000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
200000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
602800000 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1856400000 USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
260000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
260000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
167169340 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
166625976 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
167136691 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
166604427 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
32649 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
21549 shares
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
370600000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
722400000 USD
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
47200000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
99300000 USD
CY2012Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
2900000 USD
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
4600000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
205300000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
389700000 USD
CY2012Q2 us-gaap Cost Of Services
CostOfServices
27200000 USD
us-gaap Cost Of Services
CostOfServices
58000000 USD
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
232500000 USD
us-gaap Cost Of Revenue
CostOfRevenue
447700000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
188200000 USD
us-gaap Gross Profit
GrossProfit
378600000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
110600000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
215000000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51900000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
100100000 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
166100000 USD
us-gaap Operating Expenses
OperatingExpenses
322100000 USD
us-gaap Inventory Write Down
InventoryWriteDown
14100000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19300000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46200000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
58600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3800000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4300000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-15500000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-5800000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
22900000 USD
us-gaap Net Income Loss
NetIncomeLoss
28300000 USD
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
253300000 USD
us-gaap Cost Of Revenue
CostOfRevenue
472200000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
201600000 USD
us-gaap Gross Profit
GrossProfit
376100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28600000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-400000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1100000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-36600000 USD
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
22200000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4900000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
41900000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21700000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
30400000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1700000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-50400000 USD
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
500000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-24900000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-32100000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
216500000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
20000000 USD
us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
240000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
26300000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1400000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3400000 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
-1100000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
600000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
17500000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2700000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-14700000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-5700000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-59700000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
246000000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240300000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
250900000 USD

Files In Submission

Name View Source Status
0001104659-13-061802-index-headers.html Edgar Link pending
0001104659-13-061802-index.html Edgar Link pending
0001104659-13-061802.txt Edgar Link pending
0001104659-13-061802-xbrl.zip Edgar Link pending
a13-13787_110q.htm Edgar Link pending
a13-13787_1ex31d1.htm Edgar Link pending
a13-13787_1ex31d2.htm Edgar Link pending
a13-13787_1ex32d1.htm Edgar Link pending
brkr-20130630.xml Edgar Link completed
brkr-20130630.xsd Edgar Link pending
brkr-20130630_cal.xml Edgar Link unprocessable
brkr-20130630_def.xml Edgar Link unprocessable
brkr-20130630_lab.xml Edgar Link unprocessable
brkr-20130630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending